Airway Clearance Devices

Diseases such as chronic obstructive pulmonary disease (COPD)/ bronchiectasis, cystic fibrosis, quadriplegia and other neuromuscular disorders can reduce lung function, increase mucus production and interfere with proper breathing. Increased mucus production and retention of excess mucus increase the risk of lung infections.

Learning how to effectively clear mucus from the air passages is extremely important. Airway clearance therapy can loosen thick mucus secretions so it can be mobilized from your lungs by coughing or huffing. Clearing the airways may help decrease lung infections, reduce antibiotic use and hospitalization, and improve lung function.

  • The AffloVest is the first battery operated High Frequency Chest Wall Oscillation (HFCWO) airway clearance therapy that was scientifically engineered to closely mimic manual CPT, the gold standard in airway clearance therapy. Patented Direct Dynamic Oscillation™ technology can help loosen and mobilize secretions. With no bulky hoses or generators, the AffloVest is engineered to encourage compliance by allowing patients to experience an improved quality of life with full mobility during treatment.

    The AffloVest has eight oscillating motors creating eight individual pressure wave forms that closely mimic manual CPT, providing disruption in the lungs and mobilizing secretions, helping the body’s task of discharging harmful excess secretions. These individual motors allow AffloVest to target different areas of the lungs.

  • The Revolutionary Lung Flute - A first in secretion mobilization and induction. The Lung Flute is the only device FDA cleared for both diagnostic and therapeutic secretion mobilization.


  • CoughAssist T70 - Airway clearance device - CoughAssist T70 clears secretions from the lungs by gradually applying positive air pressure to the airway and then rapidly shifting to negative air pressure . The resulting high expiratory flow simulates a deep, natural cough.

 

 

News & Updates

Sign up for updates and follow us on social media.